What is the role of HER-2/neu and trastuzumab (HERCEPTIN®) in lung cancer?

被引:8
作者
Hirsch, FR [1 ]
Franklin, WA [1 ]
Bunn, PA [1 ]
机构
[1] Univ Colorado, Ctr Canc, Denver, CO 80224 USA
关键词
D O I
10.1016/S0169-5002(02)00011-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:263 / 264
页数:2
相关论文
共 8 条
[1]  
Bunn PA, 2001, CLIN CANCER RES, V7, P3239
[2]   HER2/neu expression in malignant lung tumors [J].
Hirsch, FR ;
Franklin, WA ;
Veve, R ;
Varella-Garcia, M ;
Bunn, PA .
SEMINARS IN ONCOLOGY, 2002, 29 (01) :51-58
[3]  
HIRSCH FR, 2000, P AN M AM SOC CLIN, V19, P486
[4]   C-erbB-2 expression in small-cell lung cancer is associated with poor prognosis [J].
Micke, P ;
Hengstler, JG ;
Ros, R ;
Bittinger, F ;
Metz, T ;
Gebhard, S ;
Beeh, KM ;
Oesch, F .
INTERNATIONAL JOURNAL OF CANCER, 2001, 92 (04) :474-479
[5]   Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer:: A direct comparison of fluorescence in situ hybridization and immunohistochemistry [J].
Pauletti, G ;
Dandekar, S ;
Rong, HM ;
Ramos, L ;
Pong, HJ ;
Seshadri, R ;
Slamon, DJ .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (21) :3651-3664
[6]   Predictive role of HER-2/neu overexpression and clinical features at initial presentation in patients with extensive stage small cell lung carcinoma [J].
Potti, A ;
Willardson, J ;
Forseen, C ;
Ganti, AK ;
Koch, M ;
Hebert, B ;
Levitt, R ;
Mehdi, SA .
LUNG CANCER, 2002, 36 (03) :257-261
[7]   Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. [J].
Slamon, DJ ;
Leyland-Jones, B ;
Shak, S ;
Fuchs, H ;
Paton, V ;
Bajamonde, A ;
Fleming, T ;
Eiermann, W ;
Wolter, J ;
Pegram, M ;
Baselga, J ;
Norton, L .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (11) :783-792
[8]   HUMAN-BREAST CANCER - CORRELATION OF RELAPSE AND SURVIVAL WITH AMPLIFICATION OF THE HER-2 NEU ONCOGENE [J].
SLAMON, DJ ;
CLARK, GM ;
WONG, SG ;
LEVIN, WJ ;
ULLRICH, A ;
MCGUIRE, WL .
SCIENCE, 1987, 235 (4785) :177-182